POZ - Treatment News : Blocking CD8 Cell Receptor Prolongs Survival in Monkeys

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » December 2008

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

December 11, 2008

Blocking CD8 Cell Receptor Prolongs Survival in Monkeys

Blocking a protein called PD1 on immune system cells helped reduced viral loads and increased survival in monkeys infected with a virus similar to HIV, according to the authors of a study published online December 10 in Nature and reported by ScienceDaily.

PD1 receptors are a critical component of the immune system. Their presence on CD8 cells keeps the immune system from over-reacting to infections. Two years ago, researchers reported that there is an overabundance of PD1 proteins on CD8 cells in people with HIV. The scientists proved that the excessive PD1 signaled other immune system cells to stop fighting HIV even though the virus was still present and reproducing. Additional research showed that blocking PD1 in mice improved the ability of CD8 cells to respond to a viral infection. No one knew, however, whether it would be safe to block PD1 in larger animals, such as monkeys and humans.

To explore the safety of blocking PD1, a team of researchers led by Rama Amara, PhD, from the Vaccine Research Center at Emory University in Atlanta, gave PD1-blocking antibodies to nine monkeys infected with SIV (simian immunodeficiency virus). They compared these monkeys, treated four times over a period of 10 days, with five other monkeys who were given a neutral inactive antibody.

All nine of the monkeys who received the anti-PD1 antibodies were still alive seven months after the injections, whereas four of the five monkeys who received the control antibodies died within four months. The immune systems of the monkeys who received the anti-PD1 antibodies also improved significantly, including an increased number of CD8 cells targeting SIV and production of SIV-fighting antibodies.

“It…is important to note that this therapy was effective without antiretroviral drugs and in monkeys with severe AIDS,” Amara said. The researchers plan to continue developing and refining the process for blocking PD1. They also plan to try it against other chronic diseases, such as hepatitis C virus (HCV) infection.

Search: PD1, CD8, Rama Amara, Emory University


Scroll down to comment on this story.

email print

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar
Starting Treatment
Quilt in the Capital
POZ Army


    ht2988
    Kalamazoo
    Michigan


    guycmh328
    Columbus
    Ohio


    ToPherCE
    san diego
    California


    humboman
    Baltimore
    Maryland
Click here to join POZ Personals!
Talk to Us
Poll
Do you support rapid in-home HIV testing?
Yes
No

Survey
Health 2.0

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.